-20.8%
OSCR vs THC
+407.7%
-428.4%
-94.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -7.6% | -3.8% | -3.8% | -5.7% |
| 7D | -14.1% | -7.4% | -6.8% | -10.7% |
| 30D | -15.3% | +1.9% | -17.1% | -15.9% |
| 3M | -11.9% | +0.4% | -12.3% | -12.0% |
| 6M | +9.0% | +41.0% | -32.0% | -9.7% |
| YTD | +91.9% | +36.5% | +55.3% | +59.3% |
| 1Y | +87.4% | +40.6% | +46.8% | +54.5% |
| 3Y | +262.3% | +325.7% | -63.4% | +65.7% |
| 5Y | +159.1% | +245.0% | -85.8% | +21.4% |
| All | -20.8% | +407.7% | -428.4% | -67.8% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling